Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859167 · ClinicalTrials.gov registry record
Study of the Loss of AV Synchrony at Maximum Exercise
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- 9
- Enrollment target
NCT03859167: Clinical Trial study, sponsored by Vanderbilt University Medical Center.
NCT03859167 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03859167 was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Investigators will identify a group of patients with complete heart block and a dual chamber pacemaker who will be expected to be able to exercise on a treadmill. Investigators will utilize symptom logs, cuff and continuous blood pressure monitoring. It is planned to study the symptomatic impact of loss of AV synchrony at significant levels of exercise.
Interventions
- OTHER Stress Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-09-10 |
| Est. Completion | 2023-04-10 |
Why NCT03859167 stopped before completion
NCT03859167 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Stress Test is the first listed.
NCT03859167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03859167 about?
NCT03859167 is a clinical study titled "Study of the Loss of AV Synchrony at Maximum Exercise". Investigators will identify a group of patients with complete heart block and a dual chamber pacemaker who will be expected to be able to exercise on a treadmill. Investigators will utilize symptom logs, cuff and continuous blood pressure monitoring. It is planned to study the symptomatic impact of ...
What is the current status of trial NCT03859167?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2019-09-10. Estimated completion is 2023-04-10.
What interventions are being tested in trial NCT03859167?
The interventions under investigation include: Stress Test (OTHER).
Who is sponsoring clinical trial NCT03859167?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI